MENU
SEP 30, 2020 Opens: 5:30 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

CRISPR 2020

LabRoots invites you to the 3rd Annual CRISPR Virtual Event!  This event will continue the conversation of the abilities of CRISPR-based editing, next-gen editing tools, precision in gene editing, and using CRISPR for drug discovery.

The planning committee will bring together thought leaders from academia, trained researchers from clinical laboratories, and industry experts from pharmaceutical to biotech. Experts will share case studies, experiences, and new developments regarding best practices and address appropriate alternatives that are currently being developed. 

This year's event will include the following topics and tracks:
 
Development and Classification of CRISPR Systems
  • New candidates of CRISPR systems 
  • Genetic drift and regulation of CRISPR systems

CRISPR Applications in Biomedicine and Agriculture

  • CRISPR in Gene therapy Applications
  • CRISPR for Disease Modeling in Biomedical Research 
  • CRISPR Applications in Agriculture and Crop Improvement 
  • CRISPR Applications in Synthetic Biology

CRISPR for Addressing COVID-19 Pandemic

  • CRISPR for COVID-19 diagnostics
  • CRISPR for treatment approaches

Ethical, Social, and Legal Issues in CRISPR applications

  • CRISPR Patent and Intellectual property issues 
  • Formulation of Regulatory Framework 
  • Emerging Ethical concerns of using CRISPR
  • Developing CRISPR Policy

Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open 6 months from the date of the live event.  The webinars will be available for unlimited on-demand viewing.  This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.

Like the 2019 conference, this event will be produced on our robust platform, allowing you to watch, learn, and connect seamlessly across all desktop or mobile devices. Equipped with gamification and point system, you can now move around the entire event, earning points for a chance to win one of LabRoots' most popular T-shirts.

Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary and discuss results with interested colleagues through email. Plan now to have your poster included in the 2020 CRISPR Virtual Event. Submission is free. Submit your abstract here

Continuing Education
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits.

Use #LRcrispr to follow the conversation!


Speakers

Show Resources
Agenda
Scheduled
  • Enhancing efficiency and specificity with improved CRISPR components and a new CRISPR analysis pipeline
    SEP 30, 2020 6:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Enhancing efficiency and specificity with improved CRISPR components and a new CRISPR analysis pipeline
    Ashley Jacobi
    Sr. Staff Scientist
    Sponsored By: IDT
  • Keynote Presentation: Functionalizing Genome Editing Techniques on a Broad Range of Cellular Targets
    SEP 30, 2020 7:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Keynote Presentation: Functionalizing Genome Editing Techniques on a Broad Range of Cellular Targets
    Shondra Miller, PhD/Director
    Assistant Member, Center for Advanced Genome Engineering (CAGE), St. Jude Children's Research Hospital, Department of Cell and Molecular Biology
  • Massively parallel microbial genome engineering using the Onyx™ Platform
    SEP 30, 2020 9:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Massively parallel microbial genome engineering using the Onyx™ Platform
    Nandini Krishnamurthy, PhD
    VP Applications Development, Inscripta
    Sponsored By: Inscripta
  • Straightforward CRISPR knockout: Leveraging predesigned synthetic sgRNAs for highly functional and specific gene knockout
    SEP 30, 2020 10:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Straightforward CRISPR knockout: Leveraging predesigned synthetic sgRNAs for highly functional and specific gene knockout
    James Goldmeyer, PhD
    Product Manager at Horizon Discovery
    Sponsored By: Horizon Discovery
  • SEP 30, 2020 12:00 PM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Efficient Generation of Gene-edited Mouse Models and Cell Lines Using Synthetic sgRNA
    Sponsored By: MilliporeSigma
    Gurpreet Balrey, PhD
    Head of Business for EMEA, Merck KGaA
    Peter Romanienko, PhD
    Managing Director of the Genome Editing Core Facility;...
The following webinars will be readily on-demand when the event starts
  • An Automated Integrated Multiple Assay Platform utilizing CRISPR-based Transistors for CRISPR Quality Control Applications
    An Automated Integrated Multiple Assay Platform utilizing CRISPR-based Transistors for CRISPR Quality Control Applications
    Kiana Aran, PhD
    Co-Founder and CSO, Cardea Bio
  • Applying targeted long-read sequencing to assess an expanded repeat in C9orf72
    Applying targeted long-read sequencing to assess an expanded repeat in C9orf72
    Marka van Blitterswijk, MD, PhD
    Assistant Professor of Neuroscience, Mayo Clinic
  • CRISPR/Cas9 as a tool to model and study cancer - insights and lessons learned
    CRISPR/Cas9 as a tool to model and study cancer - insights and lessons learned
    Grace R. Anderson, PhD
    Scientist, Octant
  • Elucidation of remdesivir cytotoxicity pathways through genome-wide CRISPR-Cas9 screening and transcriptomics
    Elucidation of remdesivir cytotoxicity pathways through genome-wide CRISPR-Cas9 screening and transcriptomics
    Minja Velimirovic, MSc, PhD Candidate
    Laboratory of Dr. Richard Sherwood Division of Genetics, Brigham and Women's Hospital and Harvard Medical School
  • In vivo delivery of Cas9 ribonucleoprotein and donor DNA with gold nanoparticles
    In vivo delivery of Cas9 ribonucleoprotein and donor DNA with gold nanoparticles
    Niren Murthy
    Professor of Bioengineering, University of California at Berkeley
  • Long-read sequencing reveals unforeseen CRISPR-Cas9 activity
    Long-read sequencing reveals unforeseen CRISPR-Cas9 activity
    Adam Ameur
    Associate Professor and Senior Bioinformatician, SciLifeLab, Uppsala University, Sweden
  • Measuring Outcomes of CRISPR Experiments & Leveraging Cas9 for Targeted Sequencing
    Measuring Outcomes of CRISPR Experiments & Leveraging Cas9 for Targeted Sequencing
    Jonas Korlach, PhD
    Chief Scientific Officer, Pacific Biosciences
  • CRISPR Applications in Biomedicine and Agriculture
    • CRISPR for Disease Modeling in Biomedical Research
    • Straightforward CRISPR knockout: Leveraging predesigned synthetic sgRNAs for highly functional and specific gene knockout
      SEP 30, 2020 10:30 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Straightforward CRISPR knockout: Leveraging predesigned synthetic sgRNAs for highly functional and specific gene knockout
      James Goldmeyer, PhD
      Product Manager at Horizon Discovery
      Sponsored By: Horizon Discovery
    • CRISPR in Gene Therapy Applications
    • An Automated Integrated Multiple Assay Platform utilizing CRISPR-based Transistors for CRISPR Quality Control Applications
      An Automated Integrated Multiple Assay Platform utilizing CRISPR-based Transistors for CRISPR Quality Control Applications
      Kiana Aran, PhD
      Co-Founder and CSO, Cardea Bio
  • CRISPR/Cas9 as a tool to model and study cancer - insights and lessons learned
    CRISPR/Cas9 as a tool to model and study cancer - insights and lessons learned
    Grace R. Anderson, PhD
    Scientist, Octant
Posters

POSTER SUBMISSION GUIDELINES

Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.


SUBMIT YOUR ABSTRACT

Enter the following information to this Submission Form:

  • Poster Title
  • Your Name
  • Your Institution
  • Your Email
  • Abstract describing the poster


All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

Questions? Email Posters@LabRoots.com

LabRoots Policy

Speakers

  • Adam Ameur
    Associate Professor and Senior Bioinformatician, SciLifeLab, Uppsala University, Sweden
    Biography

      Adam Ameur is associate professor and senior bioinformatician at the SciLifeLab National Genomics Infrastructure in Sweden. His work is focused on technology development and novel sequencing applications for the study of human health and disease. Ongoing activities include the construction of a whole-genome reference dataset for genetic variation in the Swedish population, as well as introduction of long-read single molecule sequencing into clinical routine. Since 2017 he is also an adjunct researcher at Monash university in Melbourne, Australia.

    • Grace R. Anderson, PhD
      Scientist, Octant
      Biography

        Originally from San Diego, CA, Grace moved to North Carolina for college and graduated from University of North Carolina at Greensboro in 2013 with a B.S. in Biology (biotechnology concentration) with chemistry and anthropology minors. In 2018, they completed their PhD in Kris Wood’s lab at Duke University in the Molecular Cancer Biology program. Their work focused on utilizing functional genomics approaches to uncover novel vulnerabilities in cancers with intrinsic or acquired resistance to anti-cancer therapies. Following graduate school, Grace was a postdoctoral fellow at Stanford University in the Genetics Department where they worked closely with another postdoc to understand the genetic liabilities associated with 3D growth in cancer spheroid models. Currently, they are a scientist at an early stage drug development company that pairs multiplexed reporter assays and high-throughput chemistry to map chemical/biological interactions.

      • Kiana Aran, PhD
        Co-Founder and CSO, Cardea Bio
        Biography

          Kiana received her PhD in Biomedical Engineering at Rutgers University. She then continued her postdoctoral studies in bio-engineering at the UC Berkeley. She is a recipient of the National Institutes of Health postdoctoral training fellowship at the Buck Institute for Age Research and is a consultant for the Gates Foundation. Kiana runs the Cardea Innovation lab at the Keck Graduate Institute of Applied Life Sciences.

        • Gurpreet Balrey, PhD
          Head of Business for EMEA, Merck KGaA
          Biography

            Dr. Gurpreet Balrey is the Head of Business for Europe, Middle East and Africa for the Genome Engineering and Modulation franchise at Merck. He attended the University of Nottingham for a Biotechnology degree followed by a PhD in Molecular Biology and Plant Genetic Engineering at the same University. Gurpreet has held various positions within the technical sales team during his 11 years with the company. He has particularly been involved in working with the Welcome Trust Sanger Institute to bring the arrayed whole genome libraries to market and more currently on our SygRNA® synthetic two part and single guide CRISPR RNA offering.

          • James Goldmeyer, PhD
            Product Manager at Horizon Discovery
            Biography

              James Goldmeyer, PhD, Product Manager at Horizon Discovery. In his extended service with the company, James has led the development and commercial launch of numerous product lines. He currently has responsibility for the Functional Genomic Screening services and library offerings and is heavily involved in the development of novel applications and screening paradigms to support client research efforts. James works closely with an expert group of R&D scientists on innovative tools and services for gene modulation and engineering. James earned a doctorate degree in physiology and neurobiology at the University of Connecticut.

            • Ashley Jacobi
              Sr. Staff Scientist
              Biography

                Ashley Jacobi is a Staff Scientist in the Molecular Genetics Research and Development group at IDT. Ashley has been with IDT for 14 years, and during that time, she has been an author on 18 manuscripts published in peer-reviewed journals, contributed to numerous patent applications, and has presented at a wide variety of international biomedical research conferences. She has been conducting research in RNAi and antisense oligo technologies, but more recently has been focusing on the development of novel CRISPR RNA sequences and modification patterns that allow for more efficient and specific cleavage by the S.p. Cas9 and A.s. Cas12a CRISPR nucleases.

              • Jonas Korlach, PhD
                Chief Scientific Officer, Pacific Biosciences
                Biography
                  Jonas Korlach was appointed Chief Scientific Officer of Pacific Biosciences in July 2012. He was previously a Scientific Fellow, supporting commercial development of the PacBio RS II system and performing research aimed at developing new applications for SMRT technologies. He co-invented the SMRT technology with Stephen Turner, Ph.D., Pacific Biosciences Founder and Chief Technology Officer, when the two were graduate students at Cornell University. Dr. Korlach joined Pacific Biosciences as the company's eighth employee in 2004. Previously, he was a Postdoctoral Researcher at Cornell University. Dr. Korlach is the recipient of multiple grants, an inventor on 70 issued U.S. patents and 61 international patents, and an author of over 100 scientific studies on the principles and applications of SMRT technology, including publications in Nature, Science, and PNAS. In 2013, Dr. Korlach was honored by the Obama White House as an Immigrant Innovator "Champion of Change." He received both his Ph.D. and his M.S. degrees in Biochemistry, Molecular and Cell Biology from Cornell, and received M.S. and B.A. degrees in Biological Sciences from Humboldt University in Berlin, Germany.
                • Nandini Krishnamurthy, PhD
                  VP Applications Development, Inscripta
                  Biography

                    Nandini Krishnamurthy leads the Microbial Applications Development team at Inscripta.  She brings greater than 15 years of research and development experience leading at the interface of experimental and computational biology. Most recently she served as Senior Research Manager, at Corteva Agriscience responsible for delivering innovative solutions in diverse trait areas using genome editing technology in multiple crops to drive differential advantage in the market. Prior to this, she has served in various positions at DuPont Pioneer, Genentech, the University of California, Berkeley, and Rockefeller University. Nandini holds a PhD in Plant Biology from Texas A&M University.

                  • Shondra Miller, PhD/Director
                    Assistant Member, Center for Advanced Genome Engineering (CAGE), St. Jude Children's Research Hospital, Department of Cell and Molecular Biology
                    Biography

                      Shondra Pruett-Miller, Ph.D. is an Assistant Member in the Department of Cell and Molecular Biology, the Founding Director of the Center for Advanced Genome Engineering (CAGE), and the Associate Director of Shared Resoucres for the Comprehensive Cancer Center at St. Jude Children’s Research Hospital in Memphis, TN.  Shondra completed her Ph.D. in Cell and Molecular Biology from The University of Texas Southwestern Medical Center in August 2008.  While at UT Southwestern, she worked in Matthew Porteus’ lab on the optimization of zinc finger nucleases for use in mammalian cells.  After graduate school, she was recruited to Sigma-Aldrich as a Senior Scientist in R&D working on their CompoZr ZFN technology.  In 2012, she returned to academia as the Founder and Director of the Genome Engineering and iPSC Center (GEiC) at Washington University School of Medicine in St. Louis.  In 2017, she joined the Faculty at St. Jude Children’s Research Hospital where she established and is directing the Center for Advanced Genome Engineering (CAGE).  Shondra has overseen the creation of over 1000 custom edited clonal cell lines, more than 250 custom edited preclinical animal models, and over 50 custom pooled gRNA screens.

                    • Niren Murthy
                      Professor of Bioengineering, University of California at Berkeley
                      Biography

                        Dr. Niren Murthy is a professor in the Department of Bioengineering at the University of California at Berkeley.  Dr. Murthy’s scientific career has focused on the molecular design and synthesis of new materials for drug delivery and molecular imaging.  The Murthy laboratory developed the hydrocyanines in 2009, which are now one of the most commonly used probes for imaging reactive oxygen species and commercially available from multiple sources.  The Murthy laboratory has developed several new nanoparticulate technologies for drug delivery, such as the polyketals, which have been used by numerous laboratories to enhance the delivery of small molecules and proteins. The Murthy laboratory has been recently focused on developing non-viral delivery vehicles that can deliver Cas9 protein, gRNA and Donor DNA in vivo.  Dr. Murthy received the NSF CAREER award in 2006, and the 2009 Society for Biomaterials Young Investigator Award.

                      • Peter Romanienko, PhD
                        Managing Director of the Genome Editing Core Facility; Rutgers Cancer Institute of New Jersey
                        Biography

                          Dr. Peter Romanienko obtained his PhD training from Cornell Graduate School of Medical Sciences/Sloan Kettering Institute working on DNA repair in Dr. Maria Jasin's laboratory and then continued working on mechanisms of DNA damage response in vivo in Dan Camerini-Otero's laboratory at NIH. After the NIH, he joined Memorial Sloan Kettering Cancer Center (MSKCC) and instituted a comprehensive mouse colony management service and supported the generation of new GEMMs. While at MSKCC, he introduced the use of gene editing to make mouse models, first with TALENS and then CRISPR-Cas9. After gaining extensive experience applying these novel methods that have revolutionized modern research, he moved to Rutgers Cancer Institute to setup and run the Genome Editing Shared Resource (GESR). While at Rutgers, the GESR has generated well over 120 novel mouse lines using CRISPR-Cas9 and also works to develop and introduce new methodologies.

                        • Marka van Blitterswijk, MD, PhD
                          Assistant Professor of Neuroscience, Mayo Clinic
                          Biography

                            Dr. Marka van Blitterswijk is an Assistant Professor and Associate Consultant in the Department of Neuroscience at Mayo Clinic. She obtained her MS degree in Bioinformatics at Johns Hopkins University (Baltimore, MD). Dr. Van Blitterswijk completed her MD and PhD degree at Utrecht University (the Netherlands). Her laboratory at Mayo Clinic focuses on the discovery of novel genes, disease modifiers, therapeutic targets, and biomarkers for neurodegenerative diseases. She is particularly interested in the most frequent genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD): a C9orf72 repeat expansion. Her laboratory employs innovative patient-oriented strategies. As a geneticist and bioinformatician, she has broad experience using various genomic technologies and analyses, such as long-read sequencing and machine learning.

                          • Minja Velimirovic, MSc, PhD Candidate
                            Laboratory of Dr. Richard Sherwood Division of Genetics, Brigham and Women's Hospital and Harvard Medical School
                            Biography

                              Minja Velimirovic is a PhD candidate working in laboratory of Dr Richard Sherwood Division of Genetics, Brigham and Women’s Hospital and Harvard Medical School. She joined the team there in January of this year, after spending prior year doing translational research with the special emphasis on the implementation of genome editing technologies for therapeutic purposes, at University of Laval in Quebec. Minja's research focuses on utilizing a suite of novel high-throughput genomic perturbation platforms, CRISPR-based genome editing and single cell RNA-sequencing.

                            Sponsored by

                            For information on becoming a sponsor or exhibitor, please click here.


                            C.E. Credits

                            The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                            Committee

                            To download the Program Committee brochure here.


                            • Dimitri Perrin

                              Dr Dimitri Perrin is Senior Lecturer in Data Science at Queensland University of Technology. Prior to joining QUT, he worked as a FPR Fellow in the Laboratory for Systems Biology (RIKEN, Japan) and as an IRCSET Marie-Curie Research Fellow with the Centre for Scientific Computing ...

                              See more See less
                            • Manush Sayd Mohammed

                              Dr. Manush Saydmohammed is currently Research Instructor at the University of Pittsburgh, PA. Prior to this, he worked as Research Associate at Uniformed Services University of the Health Sciences, Bethesda MD and as Japan Society for Promotional Sciences Post Doctoral Fellow at ...

                              See more See less
                            Help

                            General LabRoots Questions

                            email support@labroots.com  

                            Virtual Events and Webinars

                            Supported Configurations

                            • Operating System Internet Explorer Firefox Chrome Safari
                              Vista IE8+ FF10+ Chrome15+
                              Windows 7 IE8+ FF10+ Chrome15+
                              Windows 8 IE10 FF10+ Chrome15+
                              Mac OS X   FF10+ Chrome15+ Safari5.1+
                            • Cookie settings: session cookies enabled
                            • Browser configuration must have JavaScript enabled
                            • Adobe Flash player 10.2 or later

                            To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                            Internet Connection

                            • A minimum of 100Kbps is recommended for audio-only events
                            • A minimum of 300Kbps is recommended for speaker on-video events

                            Computer Equipment

                            • Screen Resolution: Minimum 1024x768
                            • Video Card: 65,000 colors minimum
                            • Sound card and speakers (or headphones) for hearing webcast in full format
                            • Audio Card: 16-bit minimum
                            • RAM: 512MB of free RAM

                            Firewall Protocol

                            • HTTP on port 80 or HTTPS on port 443
                            • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                            • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                            Work-At-Home Attendees

                            • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                            For A Seamless Experience

                            When using a mobile device, FREE Mobile Apps are available:

                            - For viewing Webinars:

                            - For viewing Virtual Events

                            Attendee Guide

                            • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                            Virtual Event and Webinar Support:

                            Continuing Education (CME/CE) Support

                            Show Resources
                            Event Countdown
                            • 0 Days
                            • 0 Hours
                            • 0 Minutes
                            • 0 Seconds
                            Attendees
                            • See more